Vepdegestrant becomes the first FDA-approved heterobifunctional protein degrader (PROTAC) in breast cancer, targeting ER ...

Endocrine therapy remains a backbone of adjuvant therapy for women with hormone receptor–positive early-stage breast cancer. Numerous studies have demonstrated the benefit of ovarian function ...

Surgery performed with its focus on one or more of the endocrine organs is referred to as endocrine surgery. The endocrine organs are glands located throughout the body, which secrete hormones that ...

Beyond weight loss, GLP-1s may offer a "two-for-one" benefit by protecting heart health, which is the leading cause of ...

FDA approval covers ER-positive/HER2-negative metastatic disease with ESR1 mutations after ≥1 endocrine line, with ...

The Endocrine Society is initiating a three-year reevaluation of its guidelines for gender-affirming care, according to a CNN report Monday. The regularly scheduled process is not related to the ...

Endocrine disruptors are defined as substances, or mixtures of substances, that interfere with the function of the endocrine system. These chemicals can act at very low doses, often exert combined or ...